ANGO Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

03

Preço $15.11

Capitalização de Mercado (MRQ) $630M

P/E (TTM) -17.2

EPS (TTM) $-0.88

Receita (TTM) $320M

ROE (TTM) -20.8%

Intervalo 52 Semanas $9–$16

ANGO Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

04

intervalo

barras

A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

06

Receita$320M

2017-05-31 → 2026-05-31

EPS$-0.88

2017-05-31 → 2026-05-31

Fluxo de caixa livre·

2017-05-31 → 2025-05-31

Margem líquida-11.5%

2017-05-31 → 2025-05-31

Avaliação e Proporções 07–12

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica	ANGO	média 5A	Mediana de Pares	Veredito
P/E (TTM)	-17.2média 5A ≈-12.5	≈-12.5	·	·
P/S (TTM)	2.0média 5A ≈1.5	≈1.5	4.2	Subvalorizado
P/B (MRQ)	3.7média 5A ≈1.6	≈1.6	3.6	Subvalorizado
Preço / FCF (TTM)	1240.3média 5A ≈-51.1	≈-51.1	·	·
Preço / Fluxo de Caixa (TTM)	204.0média 5A ≈1161.7	≈1161.7	18.9	Sobreavaliado
Preço / Valor Patrimonial Tangível (MRQ)	6.1média 5A ≈4.9	≈4.9	·	·

A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Métrica	ANGO	média 5A	Mediana de Pares	Veredito
Margem Bruta (TTM)	54.6%média 5A ≈52.2%	≈52.2%	59.1%	Fraco
Margem Operacional (TTM)	-12.5%média 5A ≈-25.3%	≈-25.3%	-10.5%	Abaixo da média
Margem de Impostos Pré-Tributação (TTM)	-11.3%média 5A ≈-25.1%	≈-25.1%	-12.9%	Em linha
Margem de Lucro Líquido (TTM)	-11.5%média 5A ≈-24.0%	≈-24.0%	-13.1%	Em linha
ROA (TTM)	-13.4%média 5A ≈-17.3%	≈-17.3%	-16.0%	Primeira linha
ROE (TTM)	-20.8%média 5A ≈-31.3%	≈-31.3%	-25.7%	Primeira linha

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Métrica	Tendência de 5 anos	ANGO	média 5A	Mediana de Pares	Veredito
Índice de liquidez corrente (MRQ)		2.2média 5A ≈2.1	≈2.1	5.1	Baixa liquidez

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métrica	ANGO	média 5A	Mediana de Pares	Veredito
Revenue YoY (Receita Ano a Ano)	9.5%média 5A ≈2.2%	≈2.2%	·	·
Revenue CAGR 3Y (CAGR Receita 3A)	-1.9%média 5A ≈1.4%	≈1.4%	·	·
Revenue CAGR 5Y (CAGR Receita 5A)	1.9%	·	·	·

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Métrica	Tendência de 5 anos	ANGO	média 5A	Mediana de Pares	Veredito
EPS (Diluted) (EPS (Diluído))		$-0.88média 5A ≈$-1.66	≈$-1.66	·	·

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Métrica	Tendência de 5 anos	ANGO	média 5A	Mediana de Pares	Veredito
Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.)		≈$506.6K	·	·	·

valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

14

Surpresa Média 76.0%

Período	EPS Actual	EPS est.	Surpresa
30 de Junho de 2026	$-0.07	$-0.09	23.7%
31 de Março de 2026	$0.02	$-0.11	117.8%
31 de Dezembro de 2025	$0.00	$-0.10	100.0%
30 de Setembro de 2025	$-0.10	$-0.12	16.6%
30 de Junho de 2025	$-0.03	$-0.12	75.5%
31 de Março de 2025	$0.03	$-0.13	122.6%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

15

Demonstração de Resultados 18

Métrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$320M	$292M	$304M	$339M	$316M	$291M	$264M	$271M	$262M	$270M	$354M	$357M
Cost of Revenue	$145M	$135M	$149M	$165M	$150M	$134M	$114M	$115M	$118M	$126M	$180M	$181M
Gross Profit	$175M	$158M	$155M	$174M	$166M	$157M	$150M	$156M	$144M	$144M	$174M	$176M
R&D Expense	$29M	$26M	$32M	$30M	$31M	$36M	$30M	$28M	$24M	$24M	$25M	$27M
SG&A Expense	$44M	$42M	$41M	$40M	$38M	$36M	$38M	$35M	$31M	$31M	$31M	$30M
Operating Expenses	$215M	$198M	$402M	$225M	$194M	$192M	$317M	$165M	$158M	$155M	$173M	$179M
Operating Income	$-40M	$-40M	$-192M	$-51M	$-28M	$-35M	$-167M	$-9M	$-14M	$-11M	$1M	$-3M
Interest Expense	·	·	$-2M	$3M	$688.0K	$861.0K	$907.0K	$5M	$3M	$3M	$3M	$3M
Interest Income	·	·	·	·	·	·	·	·	·	·	$11.0K	$4.0K
Other Non-op	$4M	$5M	$-817.0K	$-554.0K	$-790.0K	$92.0K	$-130.0K	$-207.0K	$-3M	$-3M	$-4M	$-5M
Pretax Income	$-36M	$-34M	$-192M	$-54M	$-30M	$-36M	$-168M	$-15M	$-17M	$-14M	$-3M	$-8M
Income Tax	$442.0K	$-39.0K	$-7M	$-2M	$-3M	$-5M	$-1M	$-4M	$-11M	$-7M	$40M	$-5M
Net Income	$-37M	$-34M	$-184M	$-52M	$-27M	$-32M	$-167M	$61M	$16M	$5M	$-44M	$-3M
EPS (Basic)	$-0.88	$-0.83	$-4.59	$-1.33	$-0.68	$-0.82	$-4.39	$1.64	$0.44	$0.14	$-1.21	$-0.09
EPS (Diluted)	$-0.88	$-0.83	$-4.59	$-1.33	$-0.68	$-0.82	$-4.39	$1.64	$0.44	$0.14	$-1.21	$-0.09
Shares (Basic)	41,526,000	40,853,000	40,181,000	39,480,000	39,009,000	38,342,000	37,961,000	37,485,000	37,075,000	36,617,000	36,161,000	35,683,139
Shares (Diluted)	41,526,000	40,853,000	40,181,000	39,480,000	39,009,000	38,342,000	37,961,000	37,485,000	37,075,000	36,617,000	36,161,000	35,683,139
EBITDA	·	$-40M	$-192M	$-51M	$-28M	$-35M	$-167M	$-9M	$11M	$13M	·	$-994.0K

Balanço Patrimonial 27

Métrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	$54M	$56M	$76M	$45M	$29M	$48M	$54M	$228M	$74M	$48M	$32M	$18M
Receivables	$48M	$43M	$44M	$53M	$52M	$35M	$31M	$44M	$39M	$45M	$53M	$58M
Inventory	$52M	$62M	$61M	$55M	$51M	$49M	$60M	$40M	$39M	$55M	$55M	$67M
Prepaid Expense	$9M	$8M	$13M	$5M	$11M	$9M	$7M	$4M	$4M	$6M	$3M	$4M
Current Assets	$163M	$168M	$193M	$164M	$143M	$141M	$153M	$315M	$168M	$154M	$146M	$151M
PP&E (Net)	$27M	$32M	$36M	$44M	$45M	$37M	$28M	$24M	$26M	$45M	$48M	$54M
PP&E (Gross)	·	·	$108M	$103M	$96M	$82M	$69M	$65M	$64M	$93M	$90M	$89M
Accum. Depreciation	·	·	$70M	$59M	$51M	$46M	$41M	$42M	$39M	$50M	$44M	$36M
Goodwill	·	·	$0	$159M	$201M	$201M	$201M	$348M	$286M	$361M	$361M	$361M
Intangibles	$67M	$69M	$77M	$111M	$152M	$169M	$197M	$145M	$113M	$146M	$167M	$182M
Other Non-current Assets	$9M	$10M	$11M	$11M	$11M	$13M	$15M	$4M	$3M	$2M	$4M	$5M
Total Assets	$267M	$280M	$318M	$533M	$553M	$561M	$594M	$836M	$705M	$708M	$726M	$773M
Accounts Payable	$32M	$33M	$38M	$40M	$28M	$20M	$19M	$23M	$16M	$18M	$16M	$23M
Accrued Liabilities	$39M	$36M	$41M	$27M	$35M	$35M	$29M	$38M	$34M	$39M	$22M	$18M
Current Liabilities	$75M	$76M	$91M	$84M	$74M	$58M	$51M	$73M	$57M	$72M	$67M	$61M
Capital Leases	$4M	$2M	$4M	$3M	$5M	$7M	$8M	·	·	·	·	·
Other Non-current Liabilities	$16M	$17M	$16M	$3M	$5M	$9M	$9M	$521.0K	$621.0K	$850.0K	$908.0K	$0
Total Liabilities	$96M	$97M	$112M	$154M	$128M	$122M	$139M	$222M	$163M	$193M	$219M	$228M
Long-term Debt	·	·	$0	$50M	$25M	·	·	$132M	$92M	$96M	·	·
Total Debt	·	·	·	·	·	·	$0	$132M	$92M	$96M	·	$9M
Common Stock	$387.0K	$385.0K	$385.0K	$382.0K	$380.0K	$377.0K	$374.0K	$372.0K	$370.0K	$367.0K	$363.0K	$360.0K
Retained Earnings	$-466M	$-429M	$-395M	$-211M	$-158M	$-132M	$-100M	$66M	$5M	$-11M	$-16M	$28M
Treasury Stock	$7M	$7M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$2M	$2M
AOCI	$8M	$-2M	$-4M	$-5M	$1M	$3M	$-1M	$-1M	$-952.0K	$-1M	$-791.0K	$-833.0K
Stockholders' Equity	$171M	$183M	$206M	$378M	$424M	$439M	$455M	$615M	$543M	$515M	$507M	$545M
Liabilities + Equity	$267M	$280M	$318M	$533M	$553M	$561M	$594M	$836M	$705M	$708M	$726M	$773M
Shares Outstanding	41,700,419	40,994,030	40,801,597	39,981,422	39,541,173	38,920,951	38,448,536	37,984,382	37,224,493	36,840,091	36,278,098	35,901,420

Fluxo de Caixa 17

Métrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
D&A	$23M	$26M	$28M	$31M	$29M	$26M	$24M	$26M	$23M	$25M	$28M	$30M
Stock-based Comp	$14M	$10M	$11M	$11M	$11M	$9M	$8M	$9M	$8M	$6M	$3M	$6M
Deferred Tax	$143.0K	$-988.0K	$-8M	$-2M	$-4M	$-5M	$-2M	$-4M	$-11M	$-8M	$40M	$-5M
Amort. of Intangibles	$11M	$10M	$13M	$19M	$19M	$18M	$18M	$17M	$14M	$15M	$18M	$18M
Restructuring	$13M	$14M	·	·	·	·	$26.0K	$288.0K	$5M	$1M	$0	·
Operating Cash Flow	$3M	$-10M	$-28M	$78.0K	$-7M	$24M	$-15M	$37M	$41M	$56M	$45M	$26M
CapEx	$3M	$4M	$3M	$4M	$4M	$5M	$7M	$3M	$2M	$3M	$2M	$11M
Investing Cash Flow	$-6M	$-10M	$124M	$-10M	$-19M	$-14M	$-63M	$83M	$-4M	$-3M	$-8M	$-13M
Debt Issued	·	·	·	·	·	·	·	$0	$0	$116M	$0	$15M
Net Debt Issued	·	$0	$-50M	$-45M	$0	$-20M	$-132M	$-15M	$-5M	$-24M	·	$-5M
Stock Repurchased	$0	$2M	$0	$0	·	·	·	$0	$0	$14M	$0	$0
Net Stock Activity	·	$-2M	·	·	·	·	·	$0	$0	$-14M	·	·
Financing Cash Flow	$564.0K	$-255.0K	$-64M	$25M	$8M	$-17M	$-95M	$34M	$-12M	$-38M	$-24M	$-10M
Net Change in Cash	$-2M	$-20M	$31M	$16M	$-19M	$-6M	$-173M	$154M	$27M	$15M	$14M	$2M
Taxes Paid	$405.0K	$800.0K	$455.0K	$342.0K	$329.0K	$313.0K	$682.0K	$426.0K	$36.0K	$-102.0K	$332.0K	·
Free Cash Flow	·	$-15M	$-31M	$-4M	$-11M	$19M	$-22M	$34M	$39M	$53M	·	$14M
Levered FCF	·	·	$-29M	$-6M	$-12M	$18M	$-23M	$30M	$32M	$51M	·	$13M

Lucratividade 8

Métrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Gross Margin	·	53.9%	50.9%	51.4%	52.4%	53.9%	56.9%	57.6%	51.4%	50.4%	·	49.5%
Operating Margin	·	-13.7%	-63.3%	-15.1%	-9.0%	-12.1%	-63.3%	-3.5%	3.1%	3.7%	·	-0.28%
Net Margin	·	-11.6%	-60.7%	-15.5%	-8.4%	-10.8%	-63.1%	22.7%	4.7%	1.4%	·	-0.92%
Pretax Margin	·	-11.6%	-63.1%	-16.1%	-9.5%	-12.4%	-63.6%	-5.4%	2.2%	2.8%	·	-2.2%
EBITDA Margin	·	-13.7%	-63.3%	-15.1%	-9.0%	-12.1%	-63.3%	-3.5%	3.1%	3.7%	·	-0.28%
ROA	·	-11.4%	-43.4%	-9.7%	-4.8%	-5.5%	-23.3%	8.0%	2.3%	0.70%	·	-0.42%
ROE	·	-18.4%	-86.9%	-13.5%	-6.2%	-7.0%	-31.3%	10.5%	3.1%	0.98%	·	-0.60%
ROIC	·	-21.8%	-90.0%	-13.0%	-5.9%	-7.0%	-36.4%	-0.95%	3.6%	1.1%	·	-0.07%

Liquidez e Solvência 5

Métrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Current Ratio	·	2.2	2.1	2.0	1.9	2.4	3.0	4.3	2.9	2.2	·	2.5
Quick Ratio	·	1.3	1.3	1.2	1.1	1.5	1.7	3.7	2.0	1.3	·	1.3
Debt / Equity	·	·	·	·	·	·	0.0	0.2	0.2	0.2	·	0.0
LT Debt / Equity	·	·	·	·	·	·	·	0.2	0.2	0.2	·	·
Interest Coverage	·	·	119.2	-18.9	-41.4	-41.0	-184.2	-1.8	3.4	4.6	·	-0.3

Eficiência 3

Métrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Asset Turnover	·	1.0	0.7	0.6	0.6	0.5	0.4	0.4	0.5	0.5	·	0.5
Inventory Turnover	·	2.2	2.6	3.1	3.0	2.5	2.3	2.9	3.2	3.2	·	2.6
Receivables Turnover	·	6.8	6.3	6.4	7.2	8.7	7.1	6.5	8.2	7.2	·	5.9

Por Ação 5

Métrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Book Value / Share	·	$4.46	$5.08	$9.55	$10.84	$11.40	$11.95	$16.35	$14.58	$13.98	·	$15.12
Revenue / Share	·	$7.16	$7.56	$8.58	$8.11	$7.59	$6.96	$7.22	$9.17	$9.46	·	$10.00
Cash Flow / Share	·	$-0.25	$-0.70	$0.00	$-0.18	$0.63	$-0.38	$1.00	$1.10	$1.51	·	$0.74
Cash / Share	·	$1.36	$1.88	$1.13	$0.74	$1.25	$1.43	$6.05	$1.99	$1.29	·	$0.51
EPS (TTM)	$-0.88	$-0.83	$-4.59	$-1.33	$-0.68	$-0.82	$-4.39	$1.64	$0.44	$0.14	$-1.21	$-0.09

Taxas de Crescimento 3

Métrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue YoY	9.5%	-3.8%	-10.3%	7.1%	8.7%	10.2%	·	·	·	·	·	·
Revenue CAGR 3Y	-1.9%	-2.6%	1.5%	8.6%	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	1.9%	2.1%	·	·	·	·	·	·	·	·	·	·

Avaliação (TTM) 14

Métrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue TTM	$320M	$292M	$304M	$339M	$316M	$291M	$264M	$271M	$262M	$270M	$354M	$357M
Net Income TTM	$-37M	$-34M	$-184M	$-52M	$-27M	$-32M	$-167M	$61M	$16M	$5M	$-44M	$-3M
Market Cap	·	$418M	$255M	$375M	$769M	$891M	$389M	$707M	$783M	$556M	·	$579M
Enterprise Value	·	·	·	·	·	·	$334M	$611M	$800M	$604M	·	$569M
P/E	-13.0	-12.3	-1.4	-7.1	-28.9	-28.2	-2.3	11.5	47.8	107.7	-9.9	-178.3
P/S	·	1.4	0.8	1.1	2.4	3.1	1.5	2.6	3.0	2.1	·	1.6
P/B	·	2.3	1.2	1.0	1.8	2.0	0.9	1.1	1.4	1.1	·	1.1
P / Tangible Book	4.6	3.7	2.0	3.5	10.8	12.9	6.8	·	·	·	·	·
P / Cash Flow	·	-41.3	-9.1	4804.2	-106.9	37.0	-26.7	18.9	19.0	10.0	·	22.0
P / FCF	·	-28.7	-8.3	-100.4	-66.9	47.1	-17.8	20.6	20.1	10.5	·	40.4
EV / EBITDA	·	·	·	·	·	·	-2.0	-65.0	75.8	46.6	·	-572.3
EV / FCF	·	·	·	·	·	·	-15.3	17.8	20.6	11.5	·	39.8
EV / Revenue	·	·	·	·	·	·	1.3	2.3	3.1	2.2	·	1.6
Earnings Yield	-7.7%	-8.1%	-72.7%	-14.1%	-3.5%	-3.5%	-43.0%	8.7%	2.1%	0.93%	-10.1%	-0.56%

Demonstração de Resultados 17

Métrica	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Revenue	$87M	$78M	$79M	$76M	$80M	$72M	$73M	$67M	$71M	$75M	$79M	$79M	$91M	$81M	$85M	$82M
Cost of Revenue	$40M	$37M	$35M	$34M	$38M	$33M	$33M	$31M	$32M	$39M	$39M	$39M	$45M	$40M	$40M	$39M
Gross Profit	$47M	$41M	$45M	$42M	$42M	$39M	$40M	$37M	$39M	$36M	$40M	$40M	$46M	$41M	$45M	$42M
R&D Expense	$8M	$7M	$8M	$6M	$7M	$7M	$6M	$6M	$7M	$8M	$9M	$8M	$8M	$7M	$7M	$8M
SG&A Expense	$10M	$11M	$10M	$13M	$10M	$10M	$10M	$11M	$10M	$11M	$9M	$11M	$10M	$9M	$11M	$10M
Operating Expenses	$57M	$54M	$51M	$53M	$48M	$49M	$51M	$50M	$53M	$242M	$53M	$53M	$67M	$49M	$53M	$56M
Operating Income	$-10M	$-13M	$-6M	$-11M	$-6M	$-10M	$-11M	$-13M	$-14M	$-200M	$-13M	$35M	$-21M	$-9M	$-8M	$-13M
Interest Expense	·	·	·	·	·	·	·	·	·	$-394.0K	$-534.0K	$-119.0K	·	$736.0K	$684.0K	$381.0K
Other Non-op	$-735.0K	$5M	$-128.0K	$-178.0K	$-325.0K	$5M	$12.0K	$-173.0K	$-259.0K	$-238.0K	$-32.0K	$-288.0K	$-127.0K	$0	$-252.0K	$-175.0K
Pretax Income	$-11M	$-8M	$-6M	$-11M	$-6M	$-4M	$-11M	$-13M	$-14M	$-200M	$-13M	$35M	$-22M	$-10M	$-9M	$-14M
Income Tax	$370.0K	$12.0K	$-5.0K	$65.0K	$-60.0K	$-2.0K	$-110.0K	$133.0K	$-692.0K	$-12M	$16M	$-11M	$-398.0K	$-179.0K	$-565.0K	$-853.0K
Net Income	$-11M	$-8M	$-6M	$-11M	$-6M	$-4M	$-11M	$-13M	$-13M	$-188M	$-29M	$46M	$-21M	$-9M	$-8M	$-13M
EPS (Basic)	$-0.28	$-0.19	$-0.15	$-0.26	$-0.15	$-0.11	$-0.26	$-0.31	$-0.35	$-4.67	$-0.72	$1.15	$-0.55	$-0.24	$-0.21	$-0.33
EPS (Diluted)	$-0.28	$-0.19	$-0.15	$-0.26	$-0.15	$-0.11	$-0.26	$-0.31	$-0.35	$-4.67	$-0.72	$1.15	$-0.55	$-0.24	$-0.21	$-0.33
Shares (Basic)	·	41,596,000	41,542,000	41,174,000	·	40,853,000	40,922,000	40,653,000	·	40,234,000	40,219,000	39,842,000	·	39,509,000	39,490,000	39,302,000
Shares (Diluted)	·	41,596,000	41,542,000	41,174,000	·	40,853,000	40,922,000	40,653,000	·	40,234,000	40,219,000	39,968,000	·	39,509,000	39,490,000	39,302,000
EBITDA	·	$-13M	$-6M	$-11M	·	$-10M	$-11M	$-13M	·	$-200M	$-13M	$35M	·	$-9M	$-8M	$-13M

Balanço Patrimonial 24

Métrica	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Cash & Equivalents	$54M	$38M	$42M	$39M	$56M	$45M	$54M	$55M	$76M	$78M	$61M	$58M	·	$30M	$30M	$25M
Receivables	$48M	$46M	$44M	$43M	$43M	$43M	$43M	$40M	$44M	$49M	$52M	$50M	·	$51M	$53M	$54M
Inventory	$52M	$59M	$66M	$62M	$62M	$63M	$66M	$65M	$61M	$58M	$64M	$60M	·	$64M	$63M	$58M
Prepaid Expense	$9M	$14M	$10M	$13M	$8M	$15M	$12M	$13M	$13M	$11M	$9M	$8M	·	$8M	$13M	$16M
Current Assets	$163M	$156M	$161M	$157M	$168M	$172M	$175M	$173M	$193M	$197M	$185M	$175M	·	$153M	$159M	$151M
PP&E (Net)	$27M	$29M	$31M	$31M	$32M	$33M	$33M	$34M	$36M	$37M	$43M	$43M	·	$46M	$46M	$46M
Goodwill	·	·	·	·	·	·	·	·	·	$0	$159M	$159M	·	$200M	$201M	$201M
Intangibles	$67M	$65M	$67M	$68M	$69M	$71M	$73M	$76M	$77M	$82M	$104M	$107M	·	$134M	$142M	$148M
Other Non-current Assets	$9M	$10M	$11M	$10M	$10M	$10M	$10M	$11M	$11M	$9M	$8M	$9M	·	$11M	$11M	$11M
Total Assets	$267M	$261M	$270M	$266M	$280M	$285M	$292M	$294M	$318M	$325M	$500M	$494M	·	$543M	$558M	$558M
Accounts Payable	$32M	$29M	$35M	$32M	$33M	$30M	$35M	$31M	$38M	$35M	$38M	$25M	·	$36M	$35M	$29M
Accrued Liabilities	$39M	$32M	$30M	$28M	$36M	$37M	$40M	$34M	$41M	$31M	$29M	$26M	·	$22M	$27M	$26M
Current Liabilities	$75M	$66M	$72M	$68M	$76M	$78M	$89M	$77M	$91M	$86M	$78M	$57M	·	$70M	$74M	$66M
Capital Leases	$4M	$4M	$4M	$2M	$2M	$3M	$3M	$3M	$4M	$2M	$3M	$3M	·	$3M	$3M	$4M
Other Non-current Liabilities	$16M	$17M	$17M	$14M	$17M	$17M	$12M	$16M	$16M	$14M	$3M	$3M	·	$3M	$4M	$4M
Total Liabilities	$96M	$87M	$93M	$87M	$97M	$100M	$105M	$97M	$112M	$106M	$98M	$66M	·	$145M	$150M	$144M
Long-term Debt	·	·	·	·	·	·	·	·	·	·	·	·	·	$50M	$50M	$50M
Common Stock	$387.0K	$387.0K	$386.0K	$386.0K	$385.0K	$385.0K	$384.0K	$386.0K	$385.0K	$385.0K	$383.0K	$383.0K	·	$382.0K	$381.0K	$381.0K
Retained Earnings	$-466M	$-455M	$-446M	$-440M	$-429M	$-423M	$-419M	$-408M	$-395M	$-382M	$-194M	$-165M	·	$-189M	$-180M	$-171M
Treasury Stock	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$6M	$6M	$6M	$6M	$6M	·	$6M	$6M	$6M
AOCI	$8M	$3M	$998.0K	$61.0K	$-2M	$-4M	$-4M	$-3M	$-4M	$-3M	$-5M	$-6M	·	$-4M	$-288.0K	$807.0K
Stockholders' Equity	$171M	$173M	$176M	$179M	$183M	$186M	$187M	$197M	$206M	$219M	$401M	$428M	$378M	$398M	$408M	$414M
Liabilities + Equity	$267M	$261M	$270M	$266M	$280M	$285M	$292M	$294M	$318M	$325M	$500M	$494M	·	$543M	$558M	$558M
Shares Outstanding	41,700,419	41,682,097	41,574,212	41,446,782	40,994,030	40,970,831	40,835,709	41,004,249	40,801,597	40,424,533	40,224,406	40,216,641	39,981,422	39,606,422	39,504,144	39,477,751

Fluxo de Caixa 16

Métrica	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
D&A	$6M	$6M	$6M	$6M	$6M	$6M	$7M	$7M	$7M	$8M	$7M	$7M	$8M	$8M	$8M	$8M
Stock-based Comp	$4M	$3M	$3M	$4M	$2M	$2M	$3M	$3M	$2M	$3M	$2M	$4M	$3M	$2M	$3M	$3M
Deferred Tax	$150.0K	$57.0K	$-48.0K	$-16.0K	$-193.0K	$-207.0K	$-249.0K	$-339.0K	$-825.0K	$-12M	$16M	$-11M	$-559.0K	$-227.0K	$-618.0K	$-907.0K
Amort. of Intangibles	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$5M	$5M	$5M
Restructuring	$3M	$5M	$2M	$2M	$2M	$3M	$5M	$4M	$9M	$5M	·	·	·	·	·	·
Operating Cash Flow	$17M	$-3M	$5M	$-16M	$19M	$-13M	$2M	$-18M	$5M	$-13M	$5M	$-26M	$16M	$1M	$7M	$-25M
CapEx	$413.0K	$1M	$422.0K	$731.0K	$777.0K	$2M	$797.0K	$1M	$566.0K	$607.0K	$554.0K	$791.0K	$1M	$666.0K	$1M	$809.0K
Investing Cash Flow	$-1M	$-2M	$-2M	$-2M	$-3M	$-3M	$-2M	$-2M	$-2M	$29M	$-2M	$98M	$-2M	$-2M	$-2M	$-4M
Debt Issued	·	·	·	·	·	·	·	·	·	$0	$0	$0	·	$0	$0	$70M
Net Debt Issued	·	·	·	·	·	·	·	$0	·	·	·	$-50M	·	·	·	$25M
Stock Repurchased	$0	$0	$0	$0	$0	$0	$1M	$552.0K	$0	$0	$0	$0	·	·	·	·
Net Stock Activity	·	·	·	$0	·	·	·	$-552.0K	·	·	·	·	·	·	·	·
Financing Cash Flow	$-108.0K	$621.0K	$-92.0K	$143.0K	$-6M	$7M	$-1M	$-509.0K	$-5M	$694.0K	$-352.0K	$-60M	$0	$941.0K	$103.0K	$24M
Net Change in Cash	$16M	$-4M	$3M	$-17M	$11M	$-9M	$-916.0K	$-21M	$-2M	$18M	$3M	$13M	$15M	$254.0K	$5M	$-4M
Free Cash Flow	·	·	·	$-17M	·	·	·	$-19M	·	·	·	$-27M	·	·	·	$-26M
Levered FCF	·	·	·	·	·	·	·	·	·	·	·	$-27M	·	·	·	$-26M

Lucratividade 8

Métrica	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Gross Margin	·	52.9%	56.4%	55.3%	·	54.0%	54.8%	54.4%	·	47.7%	50.9%	50.9%	·	50.2%	52.8%	51.9%
Operating Margin	·	-16.5%	-7.7%	-14.1%	·	-13.9%	-15.2%	-19.4%	·	-265.9%	-16.6%	44.5%	·	-11.1%	-9.5%	-16.3%
Net Margin	·	-10.3%	-8.0%	-14.4%	·	-6.1%	-14.7%	-19.0%	·	-249.7%	-36.7%	58.3%	·	-11.8%	-9.9%	-16.0%
Pretax Margin	·	-10.3%	-8.0%	-14.3%	·	-6.1%	-14.9%	-18.8%	·	-265.7%	-16.0%	44.3%	·	-12.0%	-10.6%	-17.0%
EBITDA Margin	·	-16.5%	-7.7%	-14.1%	·	-13.9%	-15.2%	-19.4%	·	-265.9%	-16.6%	44.5%	·	-11.1%	-9.5%	-16.3%
ROA	·	-3.0%	-2.3%	-3.9%	·	-1.4%	-2.7%	-3.2%	·	-43.3%	-5.5%	8.7%	·	-1.8%	-1.5%	-2.3%
ROE	·	-4.5%	-3.5%	-5.8%	·	-2.2%	-3.6%	-4.1%	·	-60.9%	-7.2%	10.9%	·	-2.3%	-2.0%	-3.1%
ROIC	·	-7.5%	-3.5%	-6.0%	·	-5.4%	-5.9%	-6.7%	·	-85.9%	-7.5%	10.8%	·	-2.2%	-1.9%	-3.0%

Liquidez e Solvência 3

Métrica	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Current Ratio	·	2.4	2.2	2.3	·	2.2	2.0	2.3	·	2.3	2.4	3.1	·	2.2	2.2	2.3
Quick Ratio	·	1.3	1.2	1.2	·	1.1	1.1	1.2	·	1.5	1.4	1.9	·	1.2	1.1	1.2
Interest Coverage	·	·	·	·	·	·	·	·	·	507.4	24.6	-294.4	·	-12.1	-11.9	-34.9

Eficiência 3

Métrica	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Asset Turnover	·	0.3	0.3	0.3	·	0.2	0.2	0.2	·	0.2	0.1	0.1	·	0.1	0.2	0.1
Inventory Turnover	·	0.6	0.5	0.5	·	0.5	0.5	0.5	·	0.6	0.6	0.7	·	0.7	0.7	0.7
Receivables Turnover	·	1.8	1.8	1.8	·	1.5	1.5	1.5	·	1.5	1.5	1.5	·	1.7	1.9	1.8

Por Ação 5

Métrica	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Book Value / Share	·	$4.16	$4.24	$4.32	·	$4.54	$4.57	$4.79	·	$5.41	$9.97	$10.64	·	$10.04	$10.33	$10.49
Revenue / Share	·	$1.89	$1.91	$1.84	·	$1.76	$1.78	$1.66	·	$1.87	$1.97	$1.97	·	$2.04	$2.16	$2.07
Cash Flow / Share	·	·	·	$-0.39	·	·	·	$-0.45	·	·	·	$-0.65	·	·	·	$-0.63
Cash / Share	·	$0.91	$1.00	$0.94	·	$1.09	$1.32	$1.34	·	$1.94	$1.51	$1.43	·	$0.76	$0.76	$0.62
EPS (TTM)	·	$-0.75	$-0.67	$-0.78	·	$-1.03	$-5.59	$-6.05	·	$-4.79	$-0.36	$0.15	·	$-0.94	$-0.83	$-0.83

Avaliação (TTM) 9

Métrica	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Revenue TTM	·	$314M	$307M	$301M	·	$283M	$286M	$293M	·	$324M	$330M	$336M	·	$335M	$328M	$321M
Net Income TTM	·	$-31M	$-28M	$-32M	·	$-41M	$-225M	$-243M	·	$-192M	$-14M	$6M	·	$-37M	$-33M	$-33M
Market Cap	·	$477M	$516M	$425M	·	$381M	$283M	$306M	·	$222M	$263M	$323M	·	$490M	$512M	$874M
P/E	·	-15.3	-18.5	-13.2	·	-9.0	-1.2	-1.2	·	-1.1	-18.1	53.5	·	-13.2	-15.6	-26.7
P/S	·	1.5	1.7	1.4	·	1.3	1.0	1.0	·	0.7	0.8	1.0	·	1.5	1.6	2.7
P/B	·	2.8	2.9	2.4	·	2.0	1.5	1.6	·	1.0	0.7	0.8	·	1.2	1.3	2.1
P / Tangible Book	·	4.4	4.7	3.8	·	3.3	2.5	2.5	·	1.6	1.9	2.0	·	7.7	7.8	13.4
P / Cash Flow	·	·	·	-26.7	·	·	·	-16.8	·	·	·	-12.5	·	·	·	-35.3
Earnings Yield	·	-6.6%	-5.4%	-7.6%	·	-11.1%	-80.7%	-81.1%	·	-87.2%	-5.5%	1.9%	·	-7.6%	-6.4%	-3.8%

Período mais recente à esquerda · valores nulos mostrados como ·

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

16

Métrica	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Receita	$320M	$292M	$304M	$339M	$316M
Margem Bruta %	·	53.9%	50.9%	51.4%	52.4%
Margem Operacional %	·	-13.7%	-63.3%	-15.1%	-9.0%
Lucro líquido	$-37M	$-34M	$-184M	$-52M	$-27M
EPS Diluído	$-0.88	$-0.83	$-4.59	$-1.33	$-0.68

Métrica	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Índice de liquidez corrente	·	2.2	2.1	2.0	1.9
Índice de Liquidez Seca	·	1.3	1.3	1.2	1.1

Métrica	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Fluxo de caixa livre	·	$-15M	$-31M	$-4M	$-11M

Investidores institucionais (13F) 172 declarantes · $543.8M total · Em 30 de Setembro de 2026

17

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Detentores 172

Valor detido $543.8M

Novas posições 32

Posições encerradas 15

Atividade institucional — Q2 2026 vs trimestre anterior

Novas posições	Posições encerradas	Aumentou	Diminuído	Variação líquida de ações
32 (+11 vs trimestre anterior)	15 (-17 vs trimestre anterior)	54 (-2 vs trimestre anterior)	53 (-2 vs trimestre anterior)	-445K

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição	Valor	Ações	% de 13F rastreado	Tipo
BlackRock, Inc.	$49.480.048	3.803.232	9,10%	Ações
Point72 Asset Management, L.P.	$39.843.346	3.062.517	7,33%	Ações
SYSTEMATIC FINANCIAL MANAGEMENT LP	$34.349.199	2.640.214	6,32%	Ações
VANGUARD GROUP INC	$31.288.936	2.436.833	5,75%	Ações
ARMISTICE CAPITAL, LLC	$28.595.980	2.198.000	5,26%	Ações
ROYCE & ASSOCIATES LP	$25.627.553	1.969.835	4,71%	Ações
Broadfin Holdings LLC	$23.659.114	1.818.533	4,35%	Ações
VANGUARD CAPITAL MANAGEMENT LLC	$22.048.255	1.694.716	4,05%	Ações
KOTLER KEVIN	$21.997.218	1.713.789	4,04%	Ações
WEBER CAPITAL MANAGEMENT LLC /ADV	$17.649.392	1.356.602	3,25%	Ações
Nuveen, LLC	$15.603.649	1.199.358	2,87%	Ações
GEODE CAPITAL MANAGEMENT, LLC	$13.282.661	1.020.658	2,44%	Ações
DIMENSIONAL FUND ADVISORS LP	$12.613.870	969.497	2,32%	Ações
STATE STREET CORP	$12.465.753	958.167	2,29%	Ações
SEGALL BRYANT & HAMILL, LLC	$12.056.510	926.711	2,22%	Ações
Bastion Asset Management Inc.	$10.782.584	923.270	1,98%	Ações
Pier Capital, LLC	$10.494.881	806.678	1,93%	Ações
MILLENNIUM MANAGEMENT LLC	$10.188.456	783.125	1,87%	Ações
RENAISSANCE TECHNOLOGIES LLC	$9.547.818	733.883	1,76%	Ações
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$9.009.867	692.534	1,66%	Ações
PARADIGM CAPITAL MANAGEMENT INC/NY	$8.732.312	671.200	1,61%	Ações
AQR CAPITAL MANAGEMENT LLC	$7.664.932	589.157	1,41%	Ações
VANGUARD PORTFOLIO MANAGEMENT LLC	$5.735.380	440.844	1,05%	Ações
MARSHALL WACE, LLP	$5.469.118	420.378	1,01%	Ações
Western Standard LLC	$5.037.316	387.188	0,93%	Ações
GOLDMAN SACHS GROUP INC	$4.981.750	382.917	0,92%	Ações
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$4.866.117	374.029	0,89%	Ações
BANK OF AMERICA CORP /DE/	$4.490.310	345.143	0,83%	Ações
NORTHERN TRUST CORP	$4.289.749	329.727	0,79%	Ações
TWO SIGMA INVESTMENTS, LP	$3.984.443	306.260	0,73%	Ações
Phocas Financial Corp.	$3.805.555	292.510	0,70%	Ações
VANGUARD FIDUCIARY TRUST CO	$3.602.664	276.915	0,66%	Ações
Manatuck Hill Partners, LLC	$3.597.265	276.500	0,66%	Ações
First Eagle Investment Management, LLC	$3.596.419	276.435	0,66%	Ações
PANAGORA ASSET MANAGEMENT INC	$3.363.983	258.569	0,62%	Ações
MORGAN STANLEY	$3.360.665	258.314	0,62%	Ações
TWO SIGMA ADVISERS, LP	$2.953.213	230.001	0,54%	Ações
JPMORGAN CHASE & CO	$2.914.230	220.775	0,54%	Ações
JACOBS LEVY EQUITY MANAGEMENT, INC	$2.852.104	219.224	0,52%	Ações
KENNEDY CAPITAL MANAGEMENT LLC	$2.509.967	192.926	0,46%	Ações
Orion Porfolio Solutions, LLC	$2.417.826	185.844	0,44%	Ações
MOORE CAPITAL MANAGEMENT, LP	$2.382.118	183.099	0,44%	Ações
LAZARD ASSET MANAGEMENT LLC	$2.008.471	154.379	0,37%	Ações
WHITE PINE CAPITAL LLC	$1.879.477	144.464	0,35%	Ações
Bank of New York Mellon Corp	$1.619.089	124.450	0,30%	Ações
Connor, Clark & Lunn Investment Management Ltd.	$1.577.762	121.273	0,29%	Ações
SEI INVESTMENTS CO	$1.525.673	117.269	0,28%	Ações
FMR LLC	$1.359.754	104.516	0,25%	Ações
GLOBEFLEX CAPITAL L P	$1.355.057	104.155	0,25%	Ações
Orion Portfolio Solutions, LLC	$1.324.272	141.030	0,24%	Ações

Mostrar todos os 172 proprietários institucionais →

Ativistas e proprietários de 5%+ 7 participações

18

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante	Declarado	Participação	Status	Propósito	Declaração
Avista Capital Partners GP, LLC (2), Avista Capital Partners, L.P. (2), Avista Capital Partners (Offshore), L.P. (2), Navilyst Medical Co-Invest, LLC (2) ×5 declarações	28 de Abril de 2017	·	Declaração inicial	·	SEC
Pessoa de relato não divulgada, Pessoa de relato não divulgada	23 de Dezembro de 2008	·	Declaração inicial	·	SEC
Estate of Howard S. Stern., Linda B. Stern. ×4 declarações	28 de Junho de 2007	·	Declaração inicial	·	SEC
Pessoa de relato não divulgada	16 de Maio de 2005	·	Declaração inicial	·	SEC
Pessoa de relato não divulgada	14 de Fevereiro de 2005	·	Declaração inicial	·	SEC
Pessoa de relato não divulgada	12 de Novembro de 2004	·	Declaração inicial	Investimento passivo	SEC
Pessoa de relato não divulgada	21 de Outubro de 2004	·	Declaração inicial	Investimento passivo	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Executivos da empresa 58 insiders · 27 diretores · 17 conselheiros

19

Investidor com informação privilegiada	Função	Última atividade	Ações detidas	Compras 12m	Vendas 12m	Líquido 12m
James C Clemmer	President and CEO	22 de Julho de 2026 M	862.448	1	0	$111.500
Joseph Devivo	President and CEO	8 de Setembro de 2015 F	198.451	0	0	$0
Scott J. Solano	Interim CEO	3 de Agosto de 2011 A	8.945	0	0	$0
Jan Keltjens	President & CEO	19 de Janeiro de 2011 F	109.276	0	0	$0
Stephen A Trowbridge	EVP and CFO	22 de Julho de 2026 M	305.796	1	0	$9.932
Michael Greiner	EVP and CFO	16 de Outubro de 2019 A	33.438	0	0	$0
Mark T Frost	EVP and CFO	6 de Agosto de 2015 F	38.389	0	0	$0
Joseph D Gersuk	EVP - CFO	4 de Setembro de 2012 F	47.275	0	0	$0
George W. Bourne IV	CTO and COO	6 de Agosto de 2014 F	23.613	0	0	$0
Warren Nighan JR	SVP Quality and Regulatory	30 de Julho de 2026 S	64.745	0	1	$-344.006
Laura Piccinini	SVP International	22 de Julho de 2026 M	81.929	0	0	$0
Chad Thomas Campbell	SVP/GM, Vascular Access	22 de Julho de 2026 M	108.676	0	0	$0
Lawrence T Weiss	SVP, Chief Legal Officer	15 de Julho de 2026 A	112.618	1	0	$118.100
Scott Centea	SVP/GM, VIT	19 de Julho de 2023 M	62.951	0	0	$0
Dave Helsel	SVP Global Operations and R&D	19 de Julho de 2023 M	34.462	0	0	$0
Richard C Rosenzweig	SVP and General Counsel	1 de Fevereiro de 2023 F	15.730	0	0	$0
Brent J. Boucher	SVP and GM of Oncology	12 de Fevereiro de 2020 F	15.416	0	0	$0
Robert Arthur Simpson	SVP/GM, Global Vascular	12 de Julho de 2019 M	25.883	0	0	$0
Stark Richard	SVP, GM - Oncology	15 de Novembro de 2017 M	20.754	0	0	$0
Charles R Greiner	VP - Global Franchise	6 de Maio de 2016 S	20.910	0	0	$0
John Soto	SVP and CCO	10 de Setembro de 2015 F	22.452	0	0	$0
Matthew C Kapusta	SVP, Business Development	17 de Novembro de 2014 F	30.062	0	0	$0
Stephen Mcgill	SVP, GM - International	28 de Janeiro de 2014 F	20.715	0	0	$0
Richard Scott Etlinger	SVP - Global Operations	17 de Agosto de 2012 A	11.957	0	0	$0
Alan Panzer	SVP, GM - Vascular	17 de Agosto de 2012 A	27.500	0	0	$0
Shawn P Mccarthy	SVP - General Manager	17 de Agosto de 2010 F	10.392	0	0	$0
Lynda M. Wallace	SVP - Business Development	17 de Maio de 2010 A	·	0	0	$0
Lorinda Burgess	Conselheiro	15 de Julho de 2026 A	67.144	0	0	$0
Karen A Licitra	Conselheiro	15 de Julho de 2026 A	102.322	0	0	$0
Michael E Tarnoff	Conselheiro	15 de Julho de 2026 A	95.265	0	0	$0
Eileen O'Shea Auen	Conselheiro	15 de Julho de 2026 A	116.605	0	0	$0
Wesley Johnson	Conselheiro	15 de Julho de 2026 A	155.425	0	0	$0
Howard W Donnelly	Conselheiro	15 de Julho de 2026 A	178.938	0	0	$0
Jan Stern Reed	Conselheiro	15 de Julho de 2026 A	116.921	0	0	$0
Dennis S Meteny	Conselheiro	19 de Julho de 2023 A	140.019	0	0	$0
Kevin J Gould	Conselheiro	14 de Julho de 2020 A	77.504	0	0	$0
Jeffrey Gold	Conselheiro	17 de Julho de 2019 A	83.640	0	0	$0
Steve Laporte	Conselheiro	18 de Julho de 2018 A	48.484	0	0	$0
David F Burgstahler	Conselheiro	12 de Abril de 2017 S	381.406	0	0	$0
Vincent Bucci	Conselheiro	23 de Outubro de 2013 A	88.312	0	0	$0
Charles Thomas Orsatti	Conselheiro	3 de Agosto de 2011 A	2.000	0	0	$0
Paul S Echenberg	·	23 de Abril de 2012 M	154.412	0	0	$0
Harold Mapes	·	7 de Setembro de 2010 M	14.934	0	0	$0
William M Appling	·	7 de Setembro de 2010 M	16.636	0	0	$0
Robert M Rossell	·	8 de Outubro de 2009 A	8.945	0	0	$0
Eamonn P Hobbs	·	13 de Fevereiro de 2009 S	100.401	0	0	$0
Robert E Flaherty	·	6 de Agosto de 2008 A	3.700	0	0	$0
Robert D Mitchell	·	17 de Agosto de 2007 A	1.242	0	0	$0
Daniel Recinella	·	17 de Agosto de 2007 A	1.196	0	0	$0
Brian Kunst	·	17 de Agosto de 2007 A	1.500	0	0	$0
Joseph G Gerardi	·	17 de Agosto de 2007 A	5.052	0	0	$0
Paul J Shea	·	9 de Agosto de 2007 M	2.562	0	0	$0
Linda B Stern	·	20 de Dezembro de 2006 M	0	0	0	$0
Peter J Graham	·	25 de Outubro de 2006 M	27.778	0	0	$0
Gregory D Casciaro	·	15 de Agosto de 2006 A	500	0	0	$0
David P Meyers	·	15 de Agosto de 2006 A	356.980	0	0	$0
Howard S Stern	·	28 de Dezembro de 2005 S	1.647.687	0	0	$0
EZ EM INC	·	11 de Outubro de 2004 J	0	0	0	$0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Participação em ETFs Detido por 27 ETFs

20

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo	Peso	Unidades	Em	Fonte
QQQS · Invesco Exchange-Traded Fund Trust …	0,49%	7.431 SH	2 de Outubro de 2026	Diário
DWAS · Invesco Exchange-Traded Fund Trust …	0,37%	100.041 SH	2 de Outubro de 2026	Diário
IWC · iShares Trust	0,13%	126.421 SH	11 de Setembro de 2026	Diário
IHI · iShares Trust	0,09%	197.283 SH	11 de Setembro de 2026	Diário
VFMF · VANGUARD WELLINGTON FUND	0,09%	50.141 SH	19 de Agosto de 2026	Diário
PRFZ · Invesco Exchange-Traded Fund Trust	0,04%	61.513 SH	2 de Outubro de 2026	Diário
VFQY · VANGUARD WELLINGTON FUND	0,03%	9.180 SH	19 de Agosto de 2026	Diário
VTWV · VANGUARD SCOTTSDALE FUNDS	0,02%	24.898 SH	19 de Agosto de 2026	Diário
IWM · iShares Trust	0,02%	955.368 SH	11 de Setembro de 2026	Diário
RSSL · Global X Funds	0,02%	17.796 NS	31 de Julho de 2026	N-PORT
DFAS · Dimensional ETF Trust	0,01%	137.468 NS	31 de Julho de 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	484.612 SH	19 de Agosto de 2026	Diário
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	214.186 SH	19 de Agosto de 2026	Diário
VTWG · VANGUARD SCOTTSDALE FUNDS	0,01%	9.350 SH	19 de Agosto de 2026	Diário
VHT · VANGUARD WORLD FUND	0,01%	108.819 SH	19 de Agosto de 2026	Diário
IWO · iShares Trust	0,01%	83.883 SH	11 de Setembro de 2026	Diário
DXUV · Dimensional ETF Trust	0,01%	1.917 NS	31 de Julho de 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	110.473 NS	31 de Julho de 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	5.298 NS	31 de Julho de 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	3.043 NS	31 de Julho de 2026	N-PORT
ITOT · iShares Trust	0,00%	83.876 SH	11 de Setembro de 2026	Diário
DFAU · Dimensional ETF Trust	0,00%	10.769 NS	31 de Julho de 2026	N-PORT
IWV · iShares Trust	0,00%	10.501 SH	3 de Setembro de 2026	Diário
DFUS · Dimensional ETF Trust	0,00%	9.874 NS	31 de Julho de 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	1.173.227 SH	19 de Agosto de 2026	Diário
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	2.942 SH	19 de Agosto de 2026	Diário
IWN · iShares Trust	·	259.544 SH	11 de Setembro de 2026	Diário

ANGO Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

21

classificação · 10 analistas COMPRA

Alvo mediano $19.50 +29,1%

2 20,0% Compra forte

7 70,0% Compra

1 10,0% Manter

0 0,0% Venda

0 0,0% Venda forte

Preço-alvo de 12 meses

4 analistas · 2026-10-01

Alvo médio $20.00 +32,4%

← Abaixo de todos os alvos Preço atual $15.11

Mín$17.00 Média$20.00 Máx$24.00

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

22

Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.

Ticker	Capitalização de Mercado	P/E	Receita YoY	Margem Líquida	ROE	Margem Bruta
ANGO	·	-13.0	9.5%	·	·	·
CBLL	$822M	-15.0	36.1%	-60.0%	-32.6%	87.9%
SIBN	$861M	-44.8	20.2%	-9.4%	-10.9%	79.6%
VREX	$498M	-7.0	4.1%	-8.3%	-14.0%	34.4%
AVR	$207M	-2.0	-29.2%	-4921.3%	-300.5%	·
QDEL	$1.99B	-1.8	-1.9%	-41.4%	-48.0%	·
SSII	·	-94.7	105.7%	·	·	·
DCTH	$350M	144.3	129.1%	3.2%	2.5%	86.2%
SENS	$228M	-3.3	56.9%	-196.0%	-88.7%	44.7%
ABT	$250.18B	33.7	5.7%	14.7%	13.1%	·

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

26

Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

ANGO AngioDynamics, Inc. - Common Stock